Four Leading Trial Attorneys Inducted Into 2026 Hall of Fame

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

Four prominent trial attorneys—Placitella, Rosner, Eglet, and Kline—inducted into 2026 Trial Lawyer Hall of Fame for their decades of litigation experience and significant courtroom achievements.

Four Leading Trial Attorneys Inducted Into 2026 Hall of Fame

The Trial Lawyer Hall of Fame has announced the 2026 induction of four prominent litigators: Christopher M. Placitella, Daniel E. Rosner, Robert T. Eglet, and Thomas R. Kline. The honorees will receive recognition at the MTMP Spring 2026 mass torts conference in Las Vegas, scheduled for April 15-17. Each inductee brings decades of trial experience and has established a significant track record in complex civil litigation.

The four attorneys are being recognized for their substantial contributions to the civil justice system and their achievements in obtaining notable courtroom verdicts and settlements throughout their careers. Their inclusion in the 2026 class reflects their standing among peers and their influence in advancing trial practice at both state and federal levels. The Hall of Fame selection process identifies trial lawyers who have demonstrated exceptional skill, integrity, and professional achievement.

This year's induction class underscores the continued prominence of experienced trial counsel in mass tort litigation and complex civil disputes. The recognition serves to acknowledge their professional accomplishments and their roles in shaping contemporary legal practice within the trial bar community.

Source: GlobeNewswire Inc.

Back to newsPublished Feb 18

Related Coverage

Benzinga

CVS Health Surges on Strong Q1 Earnings, Improved Cost Efficiency

CVS Health stock jumped 6.09% to 52-week high after beating Q1 earnings expectations and raising 2026 guidance, driven by improved medical cost ratios.

JNJCVS
The Motley Fool

Kimberly-Clark's Defensive Appeal: Why This Dividend Aristocrat Could Weather Market Storms

Kimberly-Clark offers defensive appeal with a 54-year dividend streak, 5.2% yield, and 15 P/E ratio despite recent 30% decline from acquisition financing concerns.

JNJKMBKVUE
GlobeNewswire Inc.

Moisturizing Cream Market to Nearly Double to $24.54B by 2035

Global moisturizing cream market projected to grow from $14.07B to $24.54B by 2035 at 5.72% CAGR, driven by natural products demand and skincare awareness.

JNJPGUL
The Motley Fool

Healthcare's Beaten-Down Gems: Why $ISRG and $VERX Deserve a $1,000 Look

Intuitive Surgical and Vertex Pharmaceuticals trade near $425-460, offering investors two shares with $1,000 despite recent sector headwinds and competitive pressures.

JNJMDTVRTX
GlobeNewswire Inc.

Wound Cleanser Market to Double to $5.17B by 2035 on Tech Advances

Global wound cleanser market valued at $3.22B in 2025, projected to reach $5.17B by 2035 at 4.92% CAGR, driven by antimicrobial technology advances and rising chronic wounds.

JNJMMMSNN
The Motley Fool

Three Healthcare Giants Positioned for Long-Term Wealth Creation

Healthcare stocks $JNJ, $VRTX, and $UNH offer compelling long-term wealth-building opportunities through strong fundamentals, dividend history, and operational improvements.

JNJUNHVRTX